Pavel Gershkovich - Publications

Simultaneous determination of a novel antitrypanosomal compound (OSU-36) and its ester derivative (OSU-40) in plasma by HPLC: application to first pharmacokinetic study in rats.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques

Published: April 20, 2011

Assessment of cholesterol absorption inhibitors nanostructured aluminosilicate and cholestyramine using in vitro lipolysis model.

Journal: Journal of pharmaceutical sciences

Published: April 08, 2011

Biodistribution and tissue toxicity of amphotericin B in mice following multiple dose administration of a novel oral lipid-based formulation (iCo-009).

Journal: The Journal of antimicrobial chemotherapy

Published: September 24, 2010

Visceral leishmaniasis affects liver and spleen concentrations of amphotericin B following administration to mice.

Journal: The Journal of antimicrobial chemotherapy

Published: December 23, 2009

Effect of hypertriglyceridemia on the pharmacokinetics and blood-brain barrier penetration of clozapine and norclozapine following administration to rats.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: October 17, 2009

Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation.

Journal: The Journal of antimicrobial chemotherapy

Published: April 29, 2009

A review of the application of lipid-based systems in systemic, dermal/ transdermal, and ocular drug delivery.

Journal: Critical reviews in therapeutic drug carrier systems

Published: January 27, 2009

Inhibition of intestinal absorption of cholesterol by surface-modified nanostructured aluminosilicate compounds.

Journal: Journal of pharmaceutical sciences

Published: December 19, 2008